Recombinant enterovirus 71 vaccine(Hansenula polymorpha)

重组肠道病毒71型疫苗（汉逊酵母）（重庆博唯佰泰生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant enterovirus 71 vaccine(Hansenula polymorpha)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHand, Foot and Mouth DiseaseEnterovirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesChongqing Bovax Biopharmaceutical Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesChongqing Bovax Biopharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsHand, Foot and Mouth DiseaseEnterovirus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A